Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Amplifon S.p.A. (AMP.MI)
EUR10.78
+0.26 (+2.47%)
IT MIL Healthcare Medical - Devices
Address
Via Ripamonti 133 20141
Milan, MI, IT
Milan, MI, IT
CEO
Enrico Vita
Website
corporate.amplifon.com
IPO
2001-10-01
ISIN IT0004056880
Also trades on
Italian Stock Exchange · AMP.MI (EUR)
Other OTC · AMFPF (USD)
Description
Amplifon S.p.A. delivers extensive hearing care products and services, empowering individuals to reconnect with the world of sound. Their diverse selection of hearing devices includes models such as ampli-easy, ampli-mini, ampli-connect, and ampli-energy, complemented by personalized fitting services for tailored solutions. As of March 18, 2022, the company maintained a substantial global presence, operating approximately 9,200 retail locations across 25 countries and five continents, further extending its reach through 1,350 franchised outlets. Amplifon conducts operations throughout Europe, the Middle East, Africa, the United States, Asia, and Oceania. The company, established in 1950, is headquartered in Milan, Italy.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
EUR10.78
+0.26 (+2.47%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
0.94
Float Shares
124.85M
Free Float %
56.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.46% | -0.18% | +8.00% | -19.34% | -18.68% | -21.37% | -43.49% | -67.94% | -67.45% | +30.90% | +355.42% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (1 ratings, all time)
Hold
Price Targets & DCF
Current price
10.78
DCF (Unlevered)
51.76
+380.4%
DCF (Levered)
34.94
+224.3%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
13% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | -1 |
| Buy | 0 | 0 |
| Hold | 14 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
1.41
Distress
Piotroski F-Score
7 / 9
Strong
MOAT Score
5 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
4 / 5
High
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
2 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%-0.6% Q1'26: -1.4% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%-37.5% Q1'26: -69.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%+5.5% Q1'26: +10.9% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%+8.3% ★ Q1'26: +9.4% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%+6.2% ★ Q1'26: +5.1% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%+0.0% ★ Q1'26: 0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×2.98× Q1'26: 3.45× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 11 Rev. Ana. 10 EPS Ana. |
Dec 2027 9 Rev. Ana. 7 EPS Ana. |
Dec 2028 6 Rev. Ana. 4 EPS Ana. |
Dec 2029 5 Rev. Ana. 2 EPS Ana. |
Dec 2030 3 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.03B
est: 1.03B (+0.9%)
|
1.13B
est: 1.13B (+0.3%)
|
1.27B
est: 1.26B (+0.5%)
|
1.36B
est: 1.36B (-0.1%)
|
1.73B
est: 1.73B (+0.3%)
|
1.56B
est: 1.56B (-0.6%)
|
1.95B
est: 1.96B (-0.5%)
|
2.12B
est: 2.13B (-0.7%)
|
2.26B
est: 2.32B (-2.7%)
|
2.41B
est: 2.41B (+0.0%)
|
2.40B
est: 2.42B (-0.8%)
|
2.43B
2.41B – 2.45B
+0.8% YoY
|
2.90B
2.82B – 3.00B
+19.1% YoY
|
3.08B
3.03B – 3.15B
+6.4% YoY
|
3.39B
3.32B – 3.46B
+9.8% YoY
|
3.71B
3.64B – 3.79B
+9.5% YoY
|
| EBITDA |
165.60M
est: 241.49M (-31.4%)
|
178.61M
est: 266.21M (-32.9%)
|
210.94M
est: 296.64M (-28.9%)
|
223.21M
est: 321.21M (-30.5%)
|
366.32M
est: 406.87M (-10.0%)
|
361.67M
est: 368.51M (-1.9%)
|
468.72M
est: 461.04M (+1.7%)
|
513.82M
est: 502.71M (+2.2%)
|
522.01M
est: 539.04M (-3.2%)
|
557.25M
est: 558.91M (-0.3%)
|
514.10M
est: 560.26M (-8.2%)
|
564.60M
559.15M – 568.55M
+0.8% YoY
|
672.32M
653.58M – 695.70M
+19.1% YoY
|
715.54M
701.92M – 730.77M
+6.4% YoY
|
786.01M
771.05M – 802.75M
+9.8% YoY
|
860.44M
844.06M – 878.76M
+9.5% YoY
|
| EBIT |
111.43M
est: 119.27M (-6.6%)
|
125.31M
est: 131.48M (-4.7%)
|
149.25M
est: 146.51M (+1.9%)
|
152.32M
est: 158.65M (-4.0%)
|
175.90M
est: 200.96M (-12.5%)
|
162.73M
est: 182.01M (-10.6%)
|
250.92M
est: 227.71M (+10.2%)
|
274.12M
est: 248.30M (+10.4%)
|
253.81M
est: 260.34M (-2.5%)
|
256.80M
est: 269.94M (-4.9%)
|
199.02M
est: 270.59M (-26.5%)
|
272.69M
270.06M – 274.59M
+0.8% YoY
|
324.71M
315.66M – 336.01M
+19.1% YoY
|
345.58M
339.01M – 352.94M
+6.4% YoY
|
379.62M
372.39M – 387.70M
+9.8% YoY
|
415.57M
407.66M – 424.42M
+9.5% YoY
|
| Net Income |
46.81M
est: 59.26M (-21.0%)
|
63.62M
est: 73.26M (-13.2%)
|
100.58M
est: 91.12M (+10.4%)
|
100.44M
est: 115.51M (-13.0%)
|
108.67M
est: 130.85M (-17.0%)
|
101.00M
est: 104.23M (-3.1%)
|
157.79M
est: 180.66M (-12.7%)
|
178.53M
est: 212.91M (-16.2%)
|
155.14M
est: 161.58M (-4.0%)
|
145.37M
est: 197.04M (-26.2%)
|
91.33M
est: 160.97M (-43.3%)
|
134.13M
112.36M – 184.73M
-16.7% YoY
|
179.61M
179.00M – 218.10M
+33.9% YoY
|
207.97M
206.09M – 244.22M
+15.8% YoY
|
253.31M
247.04M – 260.32M
+21.8% YoY
|
270.79M
264.09M – 278.28M
+6.9% YoY
|
| SGA |
55.36M
est: 99.76M (-44.5%)
|
59.67M
est: 109.97M (-45.7%)
|
71.00M
est: 122.54M (-42.1%)
|
74.73M
est: 132.70M (-43.7%)
|
9.50M
est: 168.08M (-94.3%)
|
8.69M
est: 152.23M (-94.3%)
|
10.80M
est: 190.46M (-94.3%)
|
12.39M
est: 207.67M (-94.0%)
|
22.86M
est: 223.52M (-89.8%)
|
1.11B
est: 231.77M (+377.6%)
|
—
est: 232.33M (-100.0%)
|
234.13M
231.87M – 235.76M
+0.8% YoY
|
278.79M
271.02M – 288.49M
+19.1% YoY
|
296.71M
291.07M – 303.03M
+6.4% YoY
|
325.94M
319.73M – 332.88M
+9.8% YoY
|
356.80M
350.01M – 364.40M
+9.5% YoY
|
| EPS |
0.21
est: 0.26 (-19.8%)
|
0.29
est: 0.32 (-10.4%)
|
0.46
est: 0.40 (+14.3%)
|
0.46
est: 0.51 (-9.8%)
|
0.49
est: 0.58 (-15.2%)
|
0.45
est: 0.46 (-2.3%)
|
0.70
est: 0.80 (-12.3%)
|
0.80
est: 0.94 (-14.9%)
|
0.69
est: 0.72 (-4.0%)
|
0.64
est: 0.87 (-26.4%)
|
0.40
est: 0.71 (-43.7%)
|
0.75
0.50 – 0.82
+6.0% YoY
|
0.91
0.79 – 0.96
+20.6% YoY
|
1.03
0.91 – 1.08
+12.9% YoY
|
1.12
1.09 – 1.15
+9.1% YoY
|
1.20
1.17 – 1.23
+6.9% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-08 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-07 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-06 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-05 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-04 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-30 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-29 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-28 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-27 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-24 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-23 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
139.16M
OE per share TTM
0.61
Owner's Yield
5.71%
Maintenance CapEx ratio
348.63%
Maint CapEx / Avg PPE
32.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 84 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Amundi MSCI EMU Small Cap ESG Broad Transition UCITS ETF Dist MMS.PA | 0.50% | 3.52M | 0.40% |
| 2 | Global X - Aging Population ETF AGNG | 0.33% | 281.8K | 0.50% |
| 3 | iShares MSCI EMU Small Cap UCITS ETF CES1.L | 0.30% | 3.13M | 0.58% |
| 4 | UBS MSCI EMU Small Cap UCITS ETF EUR dis UEFD.DE | 0.29% | 2.16M | 0.33% |
| 5 | Amundi FTSE MIB UCITS ETF Dist MIBX.L | 0.20% | 1.78M | 0.35% |
| 6 | iShares FTSE MIB UCITS ETF EUR (Acc) CMB1.L | 0.20% | 939.3K | 0.33% |
| 7 | iShares FTSE MIB UCITS ETF EUR (Dist) IMIB.L | 0.20% | 387.9K | 0.35% |
| 8 | Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF Dist X026.DE | 0.19% | 662.3K | 0.23% |
| 9 | Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF Acc CEM.PA | 0.19% | 662.3K | 0.23% |
| 10 | Goldman Sachs Data Enhanced International Equity ETF GIEQ | 0.19% | 19.9K | 0.30% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
17.2K
Shares Outstanding
219.94M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Enrico Vita | Chief Executive Officer, MD, GM & Executive Director | 2M | male |
| Andrea Ciccolini | Chief Information & Transformation Officer | — | male |
| Cristian Finotti | Chief Procurement & Supply Chain Officer | — | male |
| Federico Dal Poz | Chief Legal Officer & Secretary of the Board of Directors | — | male |
| Francesca Morichini | Chief HR Officer | — | female |
| Francesca Rambaudi | Investor Relations Director | — | female |
| Gabriele Galli | Chief Financial Officer | — | male |
| Iacopo Lorenzo Pazzi | Executive Vice President of EMEA | — | male |
| Alessandro Bonacina | Chief Marketing, Technology & Innovation Officer | — | male |
| Salvatore Ricco | Chief Communication Officer | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AMP.MI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
